eClinical Tech News

Collegium Pharmaceutical has launched a high-profile awareness collaboration with Paris Hilton centered on adult ADHD, with plans for Hilton...

Medicus Pharma has entered a strategic collaboration with the Gorlin Syndrome Alliance to pursue an Expanded Access IND for...

Kamada will brief investors at the Stifel 2025 Healthcare Conference in New York on November 12 at 9:20 a.m....

Seres Therapeutics has secured up to $3.6 million in additional non-dilutive funding from CARB-X to develop and manufacture an...

Fulcrum Therapeutics reported new Phase 1b data for its oral EED inhibitor, pociredir, in sickle cell disease, showing dose-dependent,...

ADMA Biologics will report third-quarter 2025 results on November 5, alongside a call to discuss performance across its plasma-derived...

Genfit will use AASLD The Liver Meeting 2025 to showcase breadth across its hepatology portfolio, led by new preclinical...

Journey Medical’s FDA-approved Emrosi (DFD-29, 40 mg minocycline hydrochloride modified-release) is now available in the United States for adults...

Health Canada has granted a Notice of Compliance with Conditions for Leqembi (lecanemab) for adults with mild cognitive impairment...

Novartis has agreed to acquire Avidity Biosciences for $12 billion in cash, consolidating control of a late-stage pipeline built...